{"id":"NCT03053362","sponsor":"Brain and Cognition Discovery Foundation","briefTitle":"THINC-it Vortioxetine - Sensitivity to Change","officialTitle":"An Open-Label Clinical Trial Evaluating Sensitivity to Change in Cognition Using the THINC-it Following Treatment With Vortioxetine in Major Depressive Disorder","status":"COMPLETED","phase":"PHASE2","dates":{"start":"2017-05-24","primaryCompletion":"2018-08-08","completion":"2018-08-08","firstPosted":"2017-02-15","resultsPosted":"2022-01-20","lastUpdate":"2025-06-08"},"enrollment":158,"design":{"allocation":"NON_RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"OTHER"},"conditions":["Major Depressive Disorder","Cognitive Change"],"interventions":[{"type":"DRUG","name":"Vortioxetine","otherNames":[]},{"type":"OTHER","name":"THINC-it Tool","otherNames":[]}],"arms":[{"label":"Major Depressive Disorder Population","type":"EXPERIMENTAL"},{"label":"Healthy Control Population","type":"OTHER"}],"summary":"The purpose of this study is to evaluate the sensitivity of the THINC-it tool, in measuring change in cognitive deficits in individuals with MDD after receiving vortioxetine.","primaryOutcome":{"measure":"Cognition Measured Using the THINC-it Tool","timeFrame":"Baseline and 8 weeks","effectByArm":[{"arm":"Major Depressive Disorder Population","deltaMin":-0.05,"sd":0.76},{"arm":"Healthy Control Population","deltaMin":-0.12,"sd":0.82}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":true,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":1,"countries":["Canada"]},"refs":{"pmids":["32670103","31404802","30766492"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":100},"commonTop":["Nausea","Gastrointestinal Upset","Headache","Dizziness/Lightheadedness","Constipation"]}}